| ²é¿´: 333 | »Ø¸´: 2 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
yalefield½ð³æ (ÎÄ̳¾«Ó¢)
ÀϺºÒ»Ã¶
|
[½»Á÷]
´ÓÅàѵÄÚÈÝ¿´»¯Ñ§ÐÅϢѧ
|
||
|
×î½üÓ¢¹úЬ·ÏîïµÃ´óѧҪ¸ãÒ»¸ö»¯Ñ§ÐÅϢѧÅàѵ£¬ÏÂÃæÊÇÌá¸Ù£º 2D databases and database searching (substructure search, virtual screening, property searching, similarity searching) Diversity and compound selection (clustering, DBCS, cell-based approaches) Quantitative Structure Activity Relationships Computational methods for 3D (introduction to molecular mechanics and conformation analysis) 3D databases (experimental data sources, database searching, pharmacophore generation) Combinatorial libraries (molecular descriptors, diversity vs focussed library design, lead- and drug-like concepts, enumeration and monomer selection) Analysis of high-throughput screening data (data mining, data visualisation) [ Last edited by yalefield on 2008-2-23 at 22:05 ] |
» ²ÂÄãϲ»¶
UJNÎïÀíѧרҵµ÷¼Á
ÒѾÓÐ12È˻ظ´
±±¾©ÄÉÃ×ÄÜÔ´ÓëϵͳÑо¿ËùÍõÖÐÁÖԺʿ/²ÜÄÏÓ±Ñо¿Ô±¿ÎÌâ×éÕÐÊÕ2026˶ʿÑо¿Éú1Ãû
ÒѾÓÐ0È˻ظ´
ÎïÀíѧIÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ251È˻ظ´
ɽÎ÷´óͬ´óѧÎïÀíѧ˶ʿÑо¿ÉúÕÐÊÕµ÷¼ÁÉú
ÒѾÓÐ0È˻ظ´
[µ÷¼ÁÐÅÏ¢]211ÖÇÄÜÈ˹¤¸ÐÖª·½Ïò¹ú¼ÒÇàÄêÌØÆ¸×¨¼Ò¿ÎÌâ×éÕÐÊÕµ÷¼ÁÑо¿Éú
ÒѾÓÐ0È˻ظ´
£Ûµ÷¼ÁÐÅÏ¢£Ý211ÖÇÄÜÈ˹¤¸ÐÖª·½Ïò¹ú¼ÒÇàÄêÌØÆ¸×¨¼Ò¿ÎÌâ×éÕÐÊÕµ÷¼ÁÑо¿Éú
ÒѾÓÐ0È˻ظ´
[µ÷¼ÁÐÅÏ¢]211ÖÇÄÜÈ˹¤¸ÐÖª·½Ïò¹ú¼ÒÇàÄêÌØÆ¸×¨¼Ò¿ÎÌâ×éÕÐÊÕµ÷¼ÁÑо¿Éú
ÒѾÓÐ0È˻ظ´
Ò»Ö¾Ô¸ÎïÀíËùÄý¾Û̬ÎïÀí352Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
0702Ò»Ö¾Ô¸¼ª´óBÇøÇóµ÷¼Á ±¾¿ÆÆÚ¼ä·¢±íһƪSci
ÒѾÓÐ2È˻ظ´
0702Ò»Ö¾Ô¸¼ª´óBÇøÇóµ÷¼Á ±¾¿ÆÆÚ¼ä·¢±íһƪSci
ÒѾÓÐ0È˻ظ´
yalefield
½ð³æ (ÎÄ̳¾«Ó¢)
ÀϺºÒ»Ã¶
- ¼ÆËãÇ¿Ìû: 2
- Ó¦Öú: 129 (¸ßÖÐÉú)
- ¹ó±ö: 0.17
- ½ð±Ò: 21238.9
- É¢½ð: 3440
- ºì»¨: 66
- Ìû×Ó: 12101
- ÔÚÏß: 759.1Сʱ
- ³æºÅ: 96063
- ×¢²á: 2005-10-07
- רҵ: ¸ßµÈ½ÌÓýѧ
- ¹ÜϽ: ¼ÆËãÄ£Äâ
3Â¥2008-02-23 22:23:50
loappleve
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1396.4
- Ìû×Ó: 282
- ÔÚÏß: 74.8Сʱ
- ³æºÅ: 124895
- ×¢²á: 2005-12-06
- ÐÔ±ð: GG
- רҵ: ÖÆÒ©
2Â¥2008-02-23 19:40:15














»Ø¸´´ËÂ¥